Laura Sears
Procedural Dermatology · Dallas, TXNPI 1942298708
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 429 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,940 and has fallen 97.0% since, to $59 in 2025.
Across 429 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$716
- Johnson & Johnson$615
- Pfizer$564
- Regeneron Healthcare Solutions, Inc.$497
- Galderma Laboratories, L.p.$482
- plus $4K from 30 others
What the payments were for
- Food & beverage$7,62498%
- Education$1472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $1,252 |
| Novartis | 35 | $716 |
| Johnson & Johnson | 27 | $615 |
| Pfizer | 35 | $564 |
| Regeneron Healthcare Solutions, Inc. | 21 | $497 |
| Galderma Laboratories, L.p. | 34 | $482 |
| Sanofi | 22 | $466 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 27 | $442 |
| LEO Pharma Inc. | 14 | $324 |
| Mayne Pharma Commercial LLC | 21 | $322 |
| Lilly USA, LLC | 16 | $301 |
| Sun Pharmaceutical Industries Inc. | 13 | $300 |
| Amgen | 18 | $228 |
| Almirall LLC | 9 | $151 |
| Incyte Corporation | 7 | $122 |
| VYNE Pharmaceuticals Inc. | 17 | $114 |
| Nabriva Therapeutics, PLC | 6 | $101 |
| EPI Health, LLC | 5 | $100 |
| Sanofi-aventis U.S. LLC | 2 | $90 |
| Journey Medical Corporation | 4 | $88 |
| Encore Dermatology Inc. | 4 | $79 |
| UCB, Inc. | 3 | $54 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $48 |
| Tactile Systems Technology Inc | 3 | $48 |
| Bristol Myers Squibb | 2 | $33 |
| Biofrontera Inc. | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Boehringer Ingelheim | 1 | $26 |
| Promius Pharma LLC | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Prugen, Inc. Pharmaceuticals | 2 | $20 |
| Aclaris Therapeutics, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Dermira, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Humira$107
How this compares
$7,771 in reported general payments places this provider in the 70th percentile of 25 procedural dermatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 17 | $165 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Dallas
- Farhad NiroomandDallas$9K
- Kathryn DuplantisDallas$399
- Daniel FriedmannAustin$146K
- Liet leKingwood$90K
- Jean-Denis BoucherLive Oak$20K
- Tho NguyenHurst$16K
- Douglas FarrisHurst$16K
- Robert OchsSan Antonio$11K
- Georganna DavisHouston$8K
- Paige HoyerEl Campo$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.